Yesterday the FDA panel heard and voted on various matters that may or may not lead to approval of Lemtrada, a Multiple Sclerosis drug.
Share this post
The FDA, statistics and fundamentalism
Share this post
Yesterday the FDA panel heard and voted on various matters that may or may not lead to approval of Lemtrada, a Multiple Sclerosis drug.